QuidelOrtho (QDEL) Other Non-Current Assets (2022 - 2026)
QuidelOrtho (QDEL) reported Other Non-Current Assets of $234.2 million for Q1 2026, down 13.32% on a YoY basis from $270.2 million in Q1 2025, and down 4.17% sequentially from $244.4 million in Q4 2025.
QuidelOrtho (QDEL) Other Non-Current Assets (2022 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 5 years of Other Non-Current Assets data on file, last reported at $234.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 13.32% year-over-year to $234.2 million; the trailing twelve-month figure through Mar 2026 stood at $234.2 million (down 13.32% YoY), and the FY2025 full-year result was $244.4 million, down 9.72% from the prior year.
- Other Non-Current Assets eased to $234.2 million in Q1 2026, from $244.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $270.7 million in Q4 2024 to a low of $19.6 million in Q1 2022.
- A 5-year average of $194.7 million and a median of $220.1 million in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets surged 526.02% in 2023 and decreased 14.39% in 2025, its largest moves.
- Tracing QDEL's Other Non-Current Assets over 5 years: stood at $164.4 million in 2022, then grew by 9.25% to $179.6 million in 2023, then soared by 50.72% to $270.7 million in 2024, then declined by 9.72% to $244.4 million in 2025, then dropped by 4.17% to $234.2 million in 2026.
- Business Quant data shows QDEL's Other Non-Current Assets at $234.2 million in Q1 2026, $244.4 million in Q4 2025, and $220.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - | 234.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 234.20 Mn |
| Dec 28, 2025 | 244.40 Mn |
| Sep 28, 2025 | 220.10 Mn |
| Jun 29, 2025 | 254.20 Mn |
| Mar 30, 2025 | 270.20 Mn |
| Dec 29, 2024 | 270.70 Mn |
| Sep 29, 2024 | 257.10 Mn |
| Jun 30, 2024 | 250.80 Mn |
| Mar 31, 2024 | 222.10 Mn |
| Dec 31, 2023 | 179.60 Mn |
| Oct 1, 2023 | 179.20 Mn |
| Jul 2, 2023 | 141.20 Mn |
| Apr 2, 2023 | 127.00 Mn |
| Jan 1, 2023 | 122.70 Mn |
| Oct 2, 2022 | 164.40 Mn |
| Jul 3, 2022 | 152.10 Mn |
| Jan 2, 2022 | 19.60 Mn |